7 insiders reported 11 Form 4 transactions for SAB Biotherapeutics, Inc. (SABS) over the past 18 months (most recent 2026-06-26). Recent activity: Kropotova Alexandra (CHIEF MEDICAL OFFICER) Sell 988 shares, Kropotova Alexandra (CHIEF MEDICAL OFFICER) Sell 988 shares, Kropotova Alexandra (CHIEF MEDICAL OFFICER) Sell 988 shares, Sessa Capital IM GP, LLC (Director) Buy 1.7M shares, Sessa Capital IM, L.P. (Director) Buy 1.7M shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-26 | Kropotova Alexandra | CHIEF MEDICAL OFFICER | Sell | 988 | $0 |
| 2026-03-25 | Kropotova Alexandra | CHIEF MEDICAL OFFICER | Sell | 988 | $0 |
| 2025-12-12 | Kropotova Alexandra | CHIEF MEDICAL OFFICER | Sell | 988 | $0 |
| 2025-10-01 | Sessa Capital IM GP, LLC | Director | Buy | 1.7M | $3.0M |
| 2025-10-01 | Sessa Capital IM, L.P. | Director | Buy | 1.7M | $3.0M |
| 2025-10-01 | Sessa Capital (Master), L.P. | Director | Buy | 1.7M | $3.0M |
| 2025-10-01 | Sessa Capital GP, LLC | Director | Buy | 1.7M | $3.0M |
| 2025-10-01 | Petry John | Director | Buy | 1.7M | $3.0M |
| 2025-10-01 | Moin Andrew | Director | Buy | 1.7M | $3.0M |
| 2025-09-22 | Kropotova Alexandra | CHIEF MEDICAL OFFICER | Sell | 1,977 | $0 |
| 2025-04-01 | Kropotova Alexandra | CHIEF MEDICAL OFFICER | Sell | 1,179 | $0 |
Source: SEC Form 4 filings · as of 2026-06-26